ProShares UltraShort NASDAQ Biotechnology
8 hedge funds and large institutions have $2.39M invested in ProShares UltraShort NASDAQ Biotechnology in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and closing their positions.
Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$943K |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$216K |
| 3 |
3
IMC Chicago
Chicago,
Illinois
|
$566K |
Top Sellers
| 1 |
OMC
1
Old Mission Capital
Chicago,
Illinois
|
$413K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$241K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$11K |
| 4 |
4
Morgan Stanley
New York
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $943K | 34,972 | +24,501 | +234% |
|
|
2
IMC Chicago
Chicago,
Illinois
| $566K | 21,003 | +2,335 | +13% |
|
|
OMC
3
Old Mission Capital
Chicago,
Illinois
| $413K | 15,311 | -16,895 | -52% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $241K | 8,946 | -6,232 | -41% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $216K | 8,002 | +8,002 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $11K | 402 | -969 | -71% |
|
|
7
Morgan Stanley
New York
| $2K | 76 | -107 | -58% |
|
8
Citigroup
New York
| $2K | 85 | – | – |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|